EconPapers    
Economics at your fingertips  
 

RNA profiles reveal signatures of future health and disease in pregnancy

Morten Rasmussen (), Mitsu Reddy, Rory Nolan, Joan Camunas-Soler, Arkady Khodursky, Nikolai M. Scheller, David E. Cantonwine, Line Engelbrechtsen, Jia Dai Mi, Arup Dutta, Tiffany Brundage, Farooq Siddiqui, Mainou Thao, Elaine P. S. Gee, Johnny La, Courtney Baruch-Gravett, Mark K. Santillan, Saikat Deb, Shaali M. Ame, Said M. Ali, Melanie Adkins, Mark A. DePristo, Manfred Lee, Eugeni Namsaraev, Dorte Jensen Gybel-Brask, Lillian Skibsted, James A. Litch, Donna A. Santillan, Sunil Sazawal, Rachel M. Tribe, James M. Roberts, Maneesh Jain, Estrid Høgdall, Claudia Holzman, Stephen R. Quake, Michal A. Elovitz () and Thomas F. McElrath ()
Additional contact information
Morten Rasmussen: Mirvie, Inc.
Mitsu Reddy: Mirvie, Inc.
Rory Nolan: Mirvie, Inc.
Joan Camunas-Soler: Mirvie, Inc.
Arkady Khodursky: Mirvie, Inc.
Nikolai M. Scheller: Statens Serum Institut
David E. Cantonwine: Brigham and Women’s Hospital
Line Engelbrechtsen: Herlev University Hospital
Jia Dai Mi: School of Life Course Sciences, Faculty of Life Sciences and Medicine, King’s College London, St Thomas’ Hospital Campus
Arup Dutta: Center for Public Health Kinetics
Tiffany Brundage: Mirvie, Inc.
Farooq Siddiqui: Mirvie, Inc.
Mainou Thao: Mirvie, Inc.
Elaine P. S. Gee: Mirvie, Inc.
Johnny La: Mirvie, Inc.
Courtney Baruch-Gravett: Global Alliance to Prevent Prematurity and Stillbirth (GAPPS)
Mark K. Santillan: University of Iowa Hospitals & Clinics
Saikat Deb: Center for Public Health Kinetics
Shaali M. Ame: Public Health Laboratory-Idc
Said M. Ali: Public Health Laboratory-Idc
Melanie Adkins: Michigan State University
Mark A. DePristo: BigHat Biosciences, Inc.
Manfred Lee: Mirvie, Inc.
Eugeni Namsaraev: Mirvie, Inc.
Dorte Jensen Gybel-Brask: Zealand University Hospital
Lillian Skibsted: Zealand University Hospital
James A. Litch: Global Alliance to Prevent Prematurity and Stillbirth (GAPPS)
Donna A. Santillan: University of Iowa Hospitals & Clinics
Sunil Sazawal: Center for Public Health Kinetics
Rachel M. Tribe: School of Life Course Sciences, Faculty of Life Sciences and Medicine, King’s College London, St Thomas’ Hospital Campus
James M. Roberts: Epidemiology and Clinical and Translational Research University of Pittsburgh
Maneesh Jain: Mirvie, Inc.
Estrid Høgdall: Herlev University Hospital
Claudia Holzman: Michigan State University
Stephen R. Quake: Stanford University
Michal A. Elovitz: Mirvie, Inc.
Thomas F. McElrath: Brigham and Women’s Hospital

Nature, 2022, vol. 601, issue 7893, 422-427

Abstract: Abstract Maternal morbidity and mortality continue to rise, and pre-eclampsia is a major driver of this burden1. Yet the ability to assess underlying pathophysiology before clinical presentation to enable identification of pregnancies at risk remains elusive. Here we demonstrate the ability of plasma cell-free RNA (cfRNA) to reveal patterns of normal pregnancy progression and determine the risk of developing pre-eclampsia months before clinical presentation. Our results centre on comprehensive transcriptome data from eight independent prospectively collected cohorts comprising 1,840 racially diverse pregnancies and retrospective analysis of 2,539 banked plasma samples. The pre-eclampsia data include 524 samples (72 cases and 452 non-cases) from two diverse independent cohorts collected 14.5 weeks (s.d., 4.5 weeks) before delivery. We show that cfRNA signatures from a single blood draw can track pregnancy progression at the placental, maternal and fetal levels and can robustly predict pre-eclampsia, with a sensitivity of 75% and a positive predictive value of 32.3% (s.d., 3%), which is superior to the state-of-the-art method2. cfRNA signatures of normal pregnancy progression and pre-eclampsia are independent of clinical factors, such as maternal age, body mass index and race, which cumulatively account for less than 1% of model variance. Further, the cfRNA signature for pre-eclampsia contains gene features linked to biological processes implicated in the underlying pathophysiology of pre-eclampsia.

Date: 2022
References: Add references at CitEc
Citations:

Downloads: (external link)
https://www.nature.com/articles/s41586-021-04249-w Abstract (text/html)
Access to the full text of the articles in this series is restricted.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:nat:nature:v:601:y:2022:i:7893:d:10.1038_s41586-021-04249-w

Ordering information: This journal article can be ordered from
https://www.nature.com/

DOI: 10.1038/s41586-021-04249-w

Access Statistics for this article

Nature is currently edited by Magdalena Skipper

More articles in Nature from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().

 
Page updated 2025-03-19
Handle: RePEc:nat:nature:v:601:y:2022:i:7893:d:10.1038_s41586-021-04249-w